That's a good point ooicomp. If I were a prospective trial patient I'd not want to go in cohorts 1 or 2. But 3 on I'd be interested in.
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%